Page 1

Medacta International Press Release - 2020 Preliminary unaudited top - line figures ● + Medacta Group SA continues to outperform the market¹ with a strong revenue acceleration in the second semester 2020 FY 2020 revenues were € 302.5 million , only -2.1 % on a constant currency basis , -2.6 % reported vs 2019 2H revenues to € 167.7 million , + 7.6 % on a constant currency basis , largely compensating 1H results 2H acceleration sustained by both pent - up demand and new customers acquired Online efforts and tactical changes in Marketing and Medical Education Programs reflected in 2H rebound Continuous innovation with 30+ new products registered Around 80 new jobs added including significant salesforce expansion across all geographies CASTEL SAN PIETRO , 21 January 2021 - Medacta Group SA ( " Medacta " , SIX : MOVE ) announces today 2020 preliminary unaudited revenues . Measures adopted by governments in response to the Covid - 19 pandemic caused the deferral of elective procedures with an impact on our sales in the first half of the year . In the following months , backlog recovery and continued acquisition of market share allowed to largely compensate the first half sales decrease , although it was limited by further restrictions from the pandemic resurgence starting in the end of October . Francesco Siccardi , CEO of Medacta , commented : " During a year strongly conditioned by the Covid - 19 pandemic in all geographies , Medacta managed to restart growing in 2H20 recovering almost completely the 1H20 negative growth . I am very satisfied with how we were able to protect our business and employees while continue to serve our customers , advance innovations and prepare for our future growth , hoping to quickly overcome the pandemic " concluded Francesco Siccardi . During the year our Marketing and Medical Education Programs never stopped , thanks to the implementation of several tactical changes and new online based initiatives which proved to be effective in maintaining existing customers and reaching new ones . Also , innovation continued and over 30 new products across our business lines were registered with more expected in the first half of this year . Growth investments carried on with significant salesforce expansion across all geographies and investment in additional surgical instruments to serve new customers . ¹ Orthopaedic industry is expected to decline 10 % i 2020. Source ORTHOWORLD , 2020 Orthopedic Market Revenue Projections , December 2020 .